U.S. STOCKS Protagonist Therapeutics, Infinera, GEO Group
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street's main stock indexes were poised for a higher open on Friday as a report closely watched by the Federal Reserve showed inflation moderating in line with expectations, strengthening hopes for early interest rate cuts this year. .N
At 9:02 ET, Dow e-minis 1YMc1 were unchanged at 39,551. S&P 500 e-minis ESc1 were up 0.17% at 5,555.5, while Nasdaq 100 e-minis NQc1 were up 0.17% at 20,074.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** Destiny Tech100 <DXYZ.N>, up 11.8%
** KORE Group Holdings <KORE.N>, up 7.8%
** Zhihu <ZH.N>, up 7.6%
The top three NYSE percentage losers premarket .PRPL.NQ:
** Wyndham Hotels & Resorts <WH.N>, down 16.3%
** NIKE <NKE.N>, down 16%
** American Well <AMWL.N>, down 10.7%
The top two Nasdaq percentage gainers premarket .PRPG.O:
** Cosmos Health <COSM.O>, up 79.7%
** Innovative Eyewear <LUCY.O>, up 42.2%
The top two Nasdaq percentage losers premarket .PRPL.O:
** Elicio Therapeutics <ELTX.O>, down 39.6%
** Nexalin Technology <NXL.O>, down 33.4%
** Nike NKE.N: down 16.0% premarket
BUZZ - Slumps after forecasting surprise revenue drop; sport retailers also decline nL4N3IQ0LE
** Apple AAPL.O: up 0.7% premarket
BUZZ - Edges higher as China shipments in May rise about 40% nL4N3IQ0O8
** Trump Media and Technology Group DJT.O: up 10.5% premarket
** Phunware PHUN.O: up 2.5% premarket
BUZZ - Stocks rise after Biden appears shaky in US presidential debate nL4N3IQ0M8
** Plug Power PLUG.O: up 6.5% premarket
BUZZ - Gains after announcing benefits of production credits nL4N3IQ0SG
** Alphabet GOOGL.O: down 0.8% premarket
BUZZ - Dips after Rosenblatt cuts to 'neutral' on AI search concerns nL4N3IQ0RL
** Protagonist Therapeutics PTGX.O: up 11.0% premarket
BUZZ - Jumps on S&P SmallCap addition nL1N3IQ0EH
** Infinera INFN.O: up 17.2% premarket
BUZZ - Jumps after $2.3 bln acquisition deal from Nokia nL4N3IQ0UM
** Rocket Pharmaceuticals Inc RCKT.O: down 13.1% premarket
BUZZ - Tumbles as FDA declines to approve its immune disorder gene therapy nL4N3IQ0VS
** GEO Group GEO.N: up 6.4% premarket
** CoreCivic CXW.N: up 4.1% premarket
BUZZ - Prison operators rise after Biden falters in debate with Trump nL4N3IQ0V2
** ARS Pharmaceuticals SPRY.O: up 5.6% premarket
BUZZ - Climbs as EU regulator recommends approval for nasal spray nL4N3IQ0WN
** Polestar Automotive Holding UK PLC PSNY.O: down 8.2% premarket
BUZZ - Falls on posting lower annual revenue nL4N3IQ0WW
** Kura Sushi USA KRUS.O: down 12.0% premarket
BUZZ - Slides on Q3 rev miss, annual rev forecast cut nL1N3IQ0IY
(Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
